Loring Wolcott & Coolidge Fiduciary Advisors LLP Arrowhead Pharmaceuticals, Inc. Transaction History

Loring Wolcott & Coolidge Fiduciary Advisors LLP

  • $11.1 Billion
  • Q2 2025

Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2021

Nov 12, 2021
SELL
$58.38 - $84.96 $6,596 - $9,600
-113 Closed
0 $0
Q2 2021

Aug 13, 2021
BUY
$62.15 - $90.32 $7,022 - $10,206
113 New
113 $9,000
Q1 2021

Apr 14, 2021
SELL
$61.35 - $90.47 $6,932 - $10,223
-113 Closed
0 $0
Q4 2020

Jan 14, 2021
BUY
$43.82 - $85.37 $4,951 - $9,646
113 New
113 $9,000

Others Institutions Holding ARWR

# of Institutions
321
Shares Held
99.1M
Call Options Held
444K
Put Options Held
568K
View Full List

About ARROWHEAD PHARMACEUTICALS, INC.

ARWR Quotes by TradingView
  • Ticker ARWR
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 105,849,000
  • Market Cap $3.82B
  • Description
  • Arrowhead Pharmaceuticals, Inc. develops medicines for the treatment of intractable diseases in the United States. The company's products in pipeline includes ARO-AAT, a RNA interference (RNAi) therapeutic candidate that is in Phase II clinical trial for the treatment of liver diseases associated with alpha-1 antitrypsin deficiency; ARO-APOC3, w...
More about ARWR
Track This Portfolio

Track Loring Wolcott & Coolidge Fiduciary Advisors LLP Portfolio

Follow Loring Wolcott & Coolidge Fiduciary Advisors LLP and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Loring Wolcott & Coolidge Fiduciary Advisors LLP, based on Form 13F filings with the SEC.

News

Stay updated on Loring Wolcott & Coolidge Fiduciary Advisors LLP with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email